LITHIUM CARBONATE

LITHIUM CARBONATE was reported 17115 times

LITHIUM CARBONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 216 0.3126
1 DYSTONIC TREMOR 16 0.1818
2 NEPHROGENIC DIABETES INSIPIDUS 195 0.1690
3 THERAPEUTIC AGENT TOXICITY 441 0.1321
4 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 110 0.1236
5 PARATHYROID GLAND ENLARGEMENT 15 0.1049
6 DISINHIBITION 163 0.1012
7 HYPERPARATHYROIDISM PRIMARY 35 0.0962
8 BODY TINEA 52 0.0929
9 ANTIPSYCHOTIC DRUG LEVEL INCREASED 246 0.0873
10 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 12 0.0811
11 HYPERPARATHYROIDISM 117 0.0567
12 PARATHYROID TUMOUR BENIGN 42 0.0566
13 RADIAL NERVE PALSY 18 0.0510
14 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 14 0.0453
15 DIABETES INSIPIDUS 104 0.0432
16 SCHIZOAFFECTIVE DISORDER 74 0.0415
17 GRANDIOSITY 15 0.0410
18 ANTIDEPRESSANT DRUG LEVEL INCREASED 14 0.0394
19 COGWHEEL RIGIDITY 41 0.0390
20 PERSISTENT DEPRESSIVE DISORDER 15 0.0371
21 BRUGADA SYNDROME 38 0.0367
22 BIPOLAR II DISORDER 13 0.0361
23 THERAPEUTIC PRODUCT EFFECT VARIABLE 140 0.0360
24 INHIBITORY DRUG INTERACTION 55 0.0347
25 HYPOMANIA 127 0.0345
26 BONE ABSCESS 14 0.0344
27 ELEVATED MOOD 15 0.0343
28 NEUROLEPTIC MALIGNANT SYNDROME 358 0.0302
29 PITTING OEDEMA 17 0.0278
30 PRESSURE OF SPEECH 18 0.0277
31 PLEUROTHOTONUS 25 0.0277
32 BIPOLAR I DISORDER 60 0.0273
33 ABULIA 25 0.0270
34 OBSESSIVE-COMPULSIVE DISORDER 217 0.0270
35 CEREBELLAR ATROPHY 23 0.0261
36 TACHYCARDIA FOETAL 13 0.0261
37 BIPOLAR DISORDER 282 0.0259
38 MANIA 424 0.0257
39 PARKINSONIAN GAIT 16 0.0256
40 ASTERIXIS 26 0.0244
41 DIABETES MELLITUS NON-INSULIN-DEPENDENT 34 0.0234
42 INFECTION SUSCEPTIBILITY INCREASED 51 0.0233
43 POLYDIPSIA 90 0.0227
44 ELECTROCARDIOGRAM T WAVE ABNORMAL 35 0.0224
45 EOSINOPHIL PERCENTAGE INCREASED 12 0.0222
46 CHOREOATHETOSIS 15 0.0221
47 DIABETIC COMA 59 0.0210
48 AKATHISIA 286 0.0209
49 BLOOD SODIUM INCREASED 56 0.0207
50 STUPOR 65 0.0202
51 RESTING TREMOR 13 0.0201
52 DYSLIPIDAEMIA 102 0.0201
53 HYPERNATRAEMIA 100 0.0200
54 HYDROPS FOETALIS 12 0.0196
55 HYPERREFLEXIA 67 0.0192
56 EUPHORIC MOOD 196 0.0191
57 CEREBELLAR SYNDROME 41 0.0187
58 SINUS ARREST 29 0.0185
59 PARKINSONISM 178 0.0182
60 FOREIGN BODY ASPIRATION 13 0.0180
61 CATATONIA 94 0.0179
62 IMPAIRED SELF-CARE 36 0.0174
63 MUTISM 25 0.0172
64 METABOLIC SYNDROME 28 0.0170
65 NEONATAL RESPIRATORY DISTRESS 16 0.0170
66 POLYURIA 139 0.0170
67 PSYCHOTIC SYMPTOM 35 0.0169
68 BORDERLINE PERSONALITY DISORDER 12 0.0169
69 PSYCHIATRIC DECOMPENSATION 33 0.0169
70 APRAXIA 25 0.0169
71 LIP EROSION 12 0.0164
72 SLEEP-RELATED EATING DISORDER 15 0.0160
73 NEGATIVISM 12 0.0158
74 LEFT ATRIAL DILATATION 20 0.0157
75 AGITATION NEONATAL 15 0.0156
76 PERSECUTORY DELUSION 39 0.0156
77 ATAXIA 185 0.0156
78 ELECTROENCEPHALOGRAM ABNORMAL 48 0.0152
79 FEELING GUILTY 20 0.0152
80 THYROTOXIC CRISIS 17 0.0149
81 MULTIPLE DRUG OVERDOSE INTENTIONAL 48 0.0149
82 STRESS URINARY INCONTINENCE 16 0.0149
83 KIDNEY ENLARGEMENT 16 0.0147
84 GLUCOSE TOLERANCE IMPAIRED 86 0.0145
85 SALIVARY HYPERSECRETION 143 0.0143
86 DEPRESSIVE SYMPTOM 50 0.0142
87 HYPOTONIA NEONATAL 22 0.0141
88 GRANULOCYTOPENIA 80 0.0140
89 CEREBELLAR ATAXIA 13 0.0136
90 ELECTROCARDIOGRAM T WAVE INVERSION 30 0.0136
91 CLONUS 37 0.0135
92 LOGORRHOEA 47 0.0133
93 PERSONALITY DISORDER 33 0.0126
94 GLYCOSURIA 17 0.0126
95 DIABETIC NEUROPATHY 61 0.0123
96 NODAL RHYTHM 18 0.0123
97 OBESITY 193 0.0121
98 PSYCHOMOTOR RETARDATION 34 0.0121
99 HYPOREFLEXIA 23 0.0120
100 SEROTONIN SYNDROME 228 0.0119
101 SOPOR 154 0.0116
102 HALLUCINATION, AUDITORY 183 0.0115
103 SINUS ARRHYTHMIA 15 0.0115
104 DRUG TOXICITY 156 0.0114
105 MYOCLONUS 135 0.0113
106 DISTRACTIBILITY 13 0.0113
107 DRUG LEVEL INCREASED 185 0.0112
108 HYPERLIPIDAEMIA 133 0.0111
109 HOMICIDAL IDEATION 45 0.0111
110 INCREASED APPETITE 211 0.0110
111 METABOLIC DISORDER 63 0.0108
112 DELUSION 168 0.0108
113 TYPE 1 DIABETES MELLITUS 65 0.0108
114 HAEMODIALYSIS 90 0.0107
115 DRUG LEVEL ABOVE THERAPEUTIC 48 0.0105
116 SINUS NODE DYSFUNCTION 19 0.0104
117 BLOOD PROLACTIN INCREASED 48 0.0102
118 SELF INJURIOUS BEHAVIOUR 31 0.0102
119 SCHIZOPHRENIA 123 0.0101
120 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 17 0.0100
121 SLOW RESPONSE TO STIMULI 13 0.0100
122 ENURESIS 40 0.0099
123 HYPERSEXUALITY 18 0.0098
124 SEDATION 257 0.0098
125 SUICIDE ATTEMPT 591 0.0097
126 MUSCLE RIGIDITY 116 0.0097
127 JUDGEMENT IMPAIRED 14 0.0096
128 GAMBLING DISORDER 26 0.0096
129 INTERNATIONAL NORMALISED RATIO ABNORMAL 33 0.0096
130 TONSILLAR HYPERTROPHY 16 0.0095
131 PSYCHOTIC DISORDER 281 0.0095
132 INAPPROPRIATE AFFECT 15 0.0095
133 GAZE PALSY 16 0.0094
134 IMPULSIVE BEHAVIOUR 35 0.0093
135 RENAL FAILURE CHRONIC 71 0.0092
136 EOSINOPHIL COUNT DECREASED 21 0.0088
137 CEREBRAL ATROPHY 35 0.0088
138 AGORAPHOBIA 12 0.0088
139 TACHYPHRENIA 30 0.0087
140 HOSTILITY 22 0.0086
141 POSTURE ABNORMAL 28 0.0086
142 NEUTROPHIL COUNT INCREASED 88 0.0086
143 EXTRAPYRAMIDAL DISORDER 213 0.0086
144 LEUKAEMIA 80 0.0085
145 BRADYPHRENIA 55 0.0084
146 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 14 0.0084
147 SELF-INJURIOUS IDEATION 35 0.0083
148 OBSESSIVE THOUGHTS 15 0.0083
149 HYPERPHAGIA 33 0.0083
150 ORAL INTAKE REDUCED 20 0.0083
151 DYSARTHRIA 309 0.0082
152 FLAT AFFECT 19 0.0082
153 NEUROTOXICITY 142 0.0081
154 MULTIPLE DRUG OVERDOSE 40 0.0081
155 GOITRE 33 0.0081
156 HYPERAMMONAEMIC ENCEPHALOPATHY 14 0.0080
157 HYPERCALCAEMIA 99 0.0080
158 ILEUS PARALYTIC 35 0.0078
159 DROOLING 54 0.0078
160 TYPE 2 DIABETES MELLITUS 263 0.0078
161 MEAN CELL VOLUME INCREASED 20 0.0078
162 COMPULSIVE SHOPPING 16 0.0078
163 SINUS BRADYCARDIA 75 0.0078
164 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0077
165 TARDIVE DYSKINESIA 217 0.0077
166 MAJOR DEPRESSION 56 0.0077
167 AFFECTIVE DISORDER 60 0.0076
168 BRUXISM 41 0.0076
169 DISORGANISED SPEECH 14 0.0076
170 PSYCHOMOTOR HYPERACTIVITY 126 0.0076
171 MENTAL STATUS CHANGES 209 0.0075
172 TOXICITY TO VARIOUS AGENTS 1267 0.0075
173 DIABETIC COMPLICATION 19 0.0075
174 COORDINATION ABNORMAL 103 0.0074
175 IMPULSE-CONTROL DISORDER 15 0.0073
176 ACUTE PSYCHOSIS 18 0.0073
177 PHYSICAL ASSAULT 15 0.0072
178 NEGATIVE THOUGHTS 21 0.0072
179 EXCORIATION 18 0.0071
180 PARANOIA 122 0.0071
181 RENAL CYST 56 0.0070
182 BLOOD TRIGLYCERIDES INCREASED 124 0.0070
183 THYROIDITIS 21 0.0070
184 LIBIDO INCREASED 14 0.0069
185 APATHY 99 0.0068
186 PARKINSON'S DISEASE 17 0.0067
187 HYPOVOLAEMIA 39 0.0067
188 TREMOR 1098 0.0066
189 BRADYKINESIA 39 0.0066
190 NYSTAGMUS 35 0.0066
191 PURPURA 58 0.0065
192 TOXIC ENCEPHALOPATHY 33 0.0065
193 URINE OUTPUT INCREASED 17 0.0065
194 HYPOTHYROIDISM 207 0.0065
195 DRUG INTERACTION 1026 0.0065
196 MUCOSAL DRYNESS 13 0.0064
197 AGITATION 474 0.0064
198 DISORIENTATION 255 0.0064
199 DELIRIUM 223 0.0064
200 BLOOD UREA INCREASED 107 0.0064
201 ELECTROCARDIOGRAM ABNORMAL 50 0.0064
202 DIABETIC NEPHROPATHY 14 0.0064
203 BUNDLE BRANCH BLOCK RIGHT 29 0.0063
204 LEUKOCYTOSIS 114 0.0063
205 PRE-EXISTING CONDITION IMPROVED 39 0.0062
206 CLUMSINESS 17 0.0062
207 ATRIOVENTRICULAR BLOCK FIRST DEGREE 27 0.0062
208 NEPHROPATHY 58 0.0062
209 DYSPHEMIA 27 0.0062
210 PRESCRIBED OVERDOSE 119 0.0061
211 DIABETES MELLITUS 468 0.0061
212 PRIAPISM 21 0.0061
213 SOCIAL AVOIDANT BEHAVIOUR 35 0.0060
214 RESTLESSNESS 218 0.0060
215 DYSTONIA 115 0.0059
216 PANCREATITIS CHRONIC 14 0.0059
217 PSYCHIATRIC SYMPTOM 43 0.0058
218 SOMNAMBULISM 38 0.0058
219 DEPRESSED LEVEL OF CONSCIOUSNESS 228 0.0058
220 AGGRESSION 288 0.0057
221 METABOLIC ENCEPHALOPATHY 17 0.0057
222 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 29 0.0057
223 SUICIDAL IDEATION 513 0.0056
224 FLUID INTAKE REDUCED 28 0.0056
225 THINKING ABNORMAL 104 0.0056
226 HYPERPROLACTINAEMIA 36 0.0055
227 SUICIDAL BEHAVIOUR 23 0.0055
228 LEFT VENTRICULAR DYSFUNCTION 37 0.0055
229 HYPERTHERMIA 42 0.0055
230 SEDATION COMPLICATION 14 0.0055
231 SUBDURAL HAEMORRHAGE 15 0.0055
232 GESTATIONAL DIABETES 26 0.0055
233 NEUTROPHILIA 31 0.0054
234 ALTERED STATE OF CONSCIOUSNESS 117 0.0054
235 SELF ESTEEM DECREASED 13 0.0054
236 WHITE BLOOD CELL COUNT INCREASED 206 0.0054
237 LEUKOPENIA 267 0.0053
238 BLOOD THYROID STIMULATING HORMONE INCREASED 49 0.0053
239 STATUS EPILEPTICUS 60 0.0053
240 POOR QUALITY SLEEP 114 0.0053
241 RED CELL DISTRIBUTION WIDTH INCREASED 22 0.0053
242 HYPERTONIA 30 0.0052
243 ENCEPHALOPATHY 128 0.0052
244 REFUSAL OF TREATMENT BY PATIENT 34 0.0052
245 EYELID DISORDER 12 0.0052
246 FAECAL INCONTINENCE 25 0.0052
247 ABNORMAL BEHAVIOUR 206 0.0052
248 INTENTIONAL SELF-INJURY 105 0.0052
249 BLOOD CHOLESTEROL ABNORMAL 24 0.0052
250 FINE MOTOR SKILL DYSFUNCTION 15 0.0052
251 DIABETES MELLITUS INADEQUATE CONTROL 91 0.0051
252 DRUG ERUPTION 91 0.0051
253 HYPERACUSIS 19 0.0051
254 BLOOD THYROID STIMULATING HORMONE DECREASED 23 0.0051
255 HYPERTHYROIDISM 73 0.0050
256 ELECTROCARDIOGRAM QT PROLONGED 181 0.0050
257 INCONTINENCE 53 0.0050
258 COMPARTMENT SYNDROME 13 0.0050
259 RENAL TUBULAR DISORDER 14 0.0050
260 BLOOD CREATINE INCREASED 22 0.0050
261 COMMUNICATION DISORDER 19 0.0050
262 RENAL FAILURE ACUTE 210 0.0049
263 FAECALOMA 27 0.0049
264 TENSION 30 0.0049
265 HYPOTHERMIA 49 0.0048
266 ANOREXIA 62 0.0048
267 NEPHROPATHY TOXIC 54 0.0048
268 INCOHERENT 31 0.0048
269 SINUS TACHYCARDIA 68 0.0048
270 DYSKINESIA 194 0.0048
271 THIRST 85 0.0048
272 DECREASED INTEREST 28 0.0047
273 MENTAL IMPAIRMENT 115 0.0047
274 IMPAIRED QUALITY OF LIFE 68 0.0047
275 BLOOD CHLORIDE DECREASED 12 0.0046
276 DIFFICULTY IN WALKING 16 0.0046
277 SELF-MEDICATION 19 0.0046
278 ALCOHOL USE 17 0.0046
279 THYROID FUNCTION TEST ABNORMAL 19 0.0046
280 MYOCARDITIS 52 0.0045
281 BLOOD CREATINE PHOSPHOKINASE INCREASED 130 0.0045
282 HYPERTONIC BLADDER 13 0.0045
283 AUTOIMMUNE THYROIDITIS 17 0.0045
284 SNORING 17 0.0045
285 GRAND MAL CONVULSION 41 0.0044
286 HYPERGLYCAEMIA 161 0.0044
287 DIABETIC RETINOPATHY 15 0.0044
288 IRRITABILITY 264 0.0044
289 DIABETIC KETOACIDOSIS 105 0.0044
290 POISONING DELIBERATE 41 0.0043
291 LOSS OF EMPLOYMENT 13 0.0043
292 SLEEP APNOEA SYNDROME 82 0.0043
293 MUSCLE CONTRACTIONS INVOLUNTARY 15 0.0043
294 DISTURBANCE IN ATTENTION 230 0.0043
295 CHRONIC SINUSITIS 16 0.0043
296 AFFECT LABILITY 41 0.0043
297 DUODENITIS 13 0.0042
298 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 14 0.0042
299 NEUROLOGICAL SYMPTOM 24 0.0042
300 PERSONALITY CHANGE 39 0.0042
301 ATRIAL SEPTAL DEFECT 35 0.0042
302 POST-TRAUMATIC STRESS DISORDER 28 0.0042
303 DRUG LEVEL BELOW THERAPEUTIC 23 0.0042
304 DIALYSIS 59 0.0042
305 URINARY INCONTINENCE 123 0.0041
306 DYSPHORIA 21 0.0041
307 IMPAIRED WORK ABILITY 88 0.0041
308 COMPLETED SUICIDE 337 0.0040
309 HALLUCINATIONS, MIXED 17 0.0040
310 CONFUSIONAL STATE 653 0.0040
311 TIC 22 0.0040
312 ATRIOVENTRICULAR BLOCK COMPLETE 27 0.0040
313 VISUAL DISTURBANCE 23 0.0040
314 HYPERAMMONAEMIA 20 0.0040
315 ATRIOVENTRICULAR BLOCK SECOND DEGREE 12 0.0040
316 TEARFULNESS 17 0.0039
317 CONJUNCTIVAL HYPERAEMIA 14 0.0039
318 HALLUCINATION, VISUAL 82 0.0039
319 BEHAVIOUR DISORDER 21 0.0039
320 PANIC DISORDER 15 0.0039
321 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 16 0.0038
322 COMA 183 0.0038
323 COGNITIVE DISORDER 177 0.0038
324 BLOOD CHOLESTEROL INCREASED 175 0.0038
325 ASPIRATION 41 0.0037
326 DRUG LEVEL DECREASED 38 0.0037
327 MENTAL DISORDER 162 0.0037
328 HYPOTONIA 37 0.0037
329 WEIGHT INCREASED 829 0.0037
330 THYROID DISORDER 57 0.0037
331 GENERALISED ERYTHEMA 21 0.0037
332 LETHARGY 211 0.0037
333 POISONING 46 0.0037
334 DISSOCIATION 28 0.0036
335 BLOOD CALCIUM INCREASED 32 0.0036
336 MUSCLE TWITCHING 84 0.0036
337 RESTLESS LEGS SYNDROME 66 0.0036
338 MIOSIS 29 0.0036
339 PANIC REACTION 26 0.0036
340 PHARYNGOLARYNGEAL PAIN 19 0.0036
341 SUBSTANCE ABUSE 29 0.0036
342 RESPIRATORY ACIDOSIS 14 0.0036
343 BLOOD CREATININE INCREASED 232 0.0035
344 ERECTILE DYSFUNCTION 91 0.0035
345 APHASIA 107 0.0035
346 MYDRIASIS 45 0.0035
347 INTENTIONAL OVERDOSE 224 0.0035
348 HYPERSOMNIA 100 0.0035
349 GAMMA-GLUTAMYLTRANSFERASE INCREASED 77 0.0035
350 TREATMENT NONCOMPLIANCE 189 0.0035
351 PRODUCT ADMINISTRATION INTERRUPTED 27 0.0034
352 SPEECH DISORDER 180 0.0034
353 ANGER 116 0.0034
354 GALACTORRHOEA 22 0.0034
355 FOOD CRAVING 18 0.0034
356 HYPERCHOLESTEROLAEMIA 33 0.0034
357 BRADYCARDIA 178 0.0034
358 NEPHROTIC SYNDROME 23 0.0034
359 CONVULSION 191 0.0033
360 APNOEA 26 0.0033
361 LEFT VENTRICULAR HYPERTROPHY 14 0.0033
362 HYPERTRIGLYCERIDAEMIA 19 0.0032
363 EOSINOPHIL COUNT INCREASED 27 0.0032
364 TACHYPNOEA 44 0.0032
365 ENERGY INCREASED 19 0.0032
366 SOMNOLENCE 647 0.0032
367 IMMOBILE 14 0.0032
368 DEPRESSION 726 0.0032
369 RHABDOMYOLYSIS 133 0.0032
370 CARDIOMYOPATHY 47 0.0032
371 TONGUE DISORDER 23 0.0032
372 CHOLECYSTITIS ACUTE 18 0.0032
373 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 28 0.0032
374 OVERWEIGHT 17 0.0032
375 RHINITIS ALLERGIC 14 0.0031
376 CARDIAC MURMUR 27 0.0031
377 CONGESTIVE CARDIOMYOPATHY 13 0.0031
378 INITIAL INSOMNIA 32 0.0031
379 SUDDEN DEATH 33 0.0031
380 STEVENS-JOHNSON SYNDROME 69 0.0031
381 STRESS CARDIOMYOPATHY 18 0.0031
382 ACTIVITIES OF DAILY LIVING IMPAIRED 61 0.0031
383 EYE MOVEMENT DISORDER 21 0.0031
384 AGRANULOCYTOSIS 57 0.0031
385 ASPHYXIA 25 0.0031
386 AMNESIA 199 0.0031
387 SLUGGISHNESS 31 0.0030
388 TROPONIN INCREASED 23 0.0030
389 MATERNAL DRUGS AFFECTING FOETUS 23 0.0030
390 SEXUAL DYSFUNCTION 35 0.0030
391 DRUG ABUSE 247 0.0030
392 PNEUMONIA ASPIRATION 74 0.0030
393 MOOD SWINGS 94 0.0029
394 DRUG SCREEN POSITIVE 23 0.0029
395 OLIGURIA 18 0.0029
396 BLOOD ALBUMIN DECREASED 23 0.0029
397 HEPATIC STEATOSIS 54 0.0029
398 HALLUCINATION 218 0.0029
399 HAEMODYNAMIC INSTABILITY 22 0.0029
400 DEPRESSED MOOD 152 0.0029
401 ATRIOVENTRICULAR BLOCK 22 0.0028
402 MOTOR DYSFUNCTION 29 0.0028
403 CHOLECYSTITIS CHRONIC 19 0.0028
404 BLOOD POTASSIUM INCREASED 46 0.0028
405 BUNDLE BRANCH BLOCK LEFT 12 0.0028
406 FEELING DRUNK 21 0.0028
407 CARDIO-RESPIRATORY ARREST 118 0.0028
408 ERYTHEMA MULTIFORME 26 0.0028
409 MOOD ALTERED 76 0.0028
410 RENAL IMPAIRMENT 234 0.0028
411 ORAL HERPES 54 0.0028
412 AMMONIA INCREASED 14 0.0027
413 PANIC ATTACK 100 0.0027
414 INSOMNIA 730 0.0027
415 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 194 0.0027
416 C-REACTIVE PROTEIN INCREASED 99 0.0027
417 TRISMUS 14 0.0027
418 STOMACH DISCOMFORT 14 0.0027
419 CARDIOTOXICITY 24 0.0027
420 RESPIRATORY ARREST 74 0.0027
421 TACHYCARDIA 238 0.0027
422 CAESAREAN SECTION 31 0.0027
423 PANCREATITIS 139 0.0026
424 HYPOKINESIA 38 0.0026
425 RESPIRATORY DEPRESSION 32 0.0026
426 HEPATIC ENZYME ABNORMAL 13 0.0026
427 VENTRICULAR TACHYCARDIA 43 0.0026
428 RESPIRATORY RATE INCREASED 23 0.0026
429 ABASIA 64 0.0026
430 HYPERVENTILATION 15 0.0026
431 ORTHOSTATIC HYPOTENSION 45 0.0026
432 INTENTIONAL DRUG MISUSE 54 0.0026
433 ELECTROLYTE IMBALANCE 30 0.0026
434 ASPARTATE AMINOTRANSFERASE INCREASED 137 0.0026
435 MITRAL VALVE INCOMPETENCE 29 0.0026
436 MENSTRUAL DISORDER 21 0.0025
437 BENIGN PROSTATIC HYPERPLASIA 13 0.0025
438 ECONOMIC PROBLEM 38 0.0025
439 GENERALISED TONIC-CLONIC SEIZURE 41 0.0025
440 WITHDRAWAL SYNDROME 104 0.0025
441 DIZZINESS POSTURAL 24 0.0025
442 NOCTURIA 30 0.0025
443 ALANINE AMINOTRANSFERASE INCREASED 151 0.0025
444 BODY TEMPERATURE INCREASED 50 0.0024
445 HYPERTRANSAMINASAEMIA 17 0.0024
446 UNRESPONSIVE TO STIMULI 63 0.0024
447 DRUG ABUSER 15 0.0024
448 DEHYDRATION 322 0.0024
449 ILEUS 30 0.0024
450 NEUTROPHIL COUNT DECREASED 98 0.0024
451 BALANCE DISORDER 207 0.0024
452 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
453 MYOCARDIAL ISCHAEMIA 27 0.0024
454 EOSINOPHILIA 41 0.0023
455 SKIN DISORDER 78 0.0023
456 GASTROENTERITIS 34 0.0023
457 HAEMATOCRIT DECREASED 46 0.0023
458 FOETAL DEATH 12 0.0023
459 ENCEPHALITIS 16 0.0023
460 EATING DISORDER 49 0.0023
461 CARDIOMEGALY 28 0.0023
462 HYPOPHAGIA 58 0.0023
463 CELLULITIS 114 0.0023
464 NEUTROPENIC SEPSIS 16 0.0022
465 HEPATOMEGALY 22 0.0022
466 HEPATITIS C 27 0.0022
467 CIRCULATORY COLLAPSE 38 0.0022
468 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 57 0.0022
469 ANXIETY 626 0.0022
470 CONCUSSION 17 0.0022
471 RENAL FAILURE 291 0.0022
472 PHOTOPHOBIA 41 0.0022
473 BLOOD SODIUM DECREASED 41 0.0022
474 ATELECTASIS 21 0.0022
475 PHARMACEUTICAL PRODUCT COMPLAINT 56 0.0022
476 HYPOGLYCAEMIA 104 0.0021
477 DYSPHAGIA 203 0.0021
478 KETOACIDOSIS 16 0.0021
479 DECREASED ACTIVITY 23 0.0021
480 FEAR 57 0.0021
481 OVERDOSE 456 0.0021
482 APPETITE DISORDER 14 0.0021
483 SLEEP DISORDER 149 0.0021
484 BLOOD ALKALINE PHOSPHATASE INCREASED 52 0.0021
485 POLLAKIURIA 86 0.0021
486 SUBARACHNOID HAEMORRHAGE 21 0.0021
487 SCREAMING 13 0.0020
488 DIPLOPIA 53 0.0020
489 URINARY RETENTION 68 0.0020
490 GLOMERULAR FILTRATION RATE DECREASED 25 0.0020
491 DRUG EXPOSURE DURING PREGNANCY 69 0.0020
492 CHRONIC KIDNEY DISEASE 154 0.0020
493 CHOLELITHIASIS 66 0.0020
494 FORMICATION 14 0.0020
495 HUNGER 28 0.0020
496 BRAIN INJURY 20 0.0020
497 LIVER FUNCTION TEST ABNORMAL 58 0.0020
498 RED BLOOD CELL COUNT DECREASED 57 0.0020
499 HEAD INJURY 63 0.0020
500 DENTAL CARIES 22 0.0020
501 HYPONATRAEMIA 112 0.0020
502 MUSCLE DISORDER 16 0.0020
503 DYSGRAPHIA 13 0.0020
504 RASH GENERALISED 51 0.0020
505 NO THERAPEUTIC RESPONSE 24 0.0020
506 ACIDOSIS 15 0.0020
507 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
508 PANCREATITIS ACUTE 44 0.0020
509 BLOOD LACTATE DEHYDROGENASE INCREASED 31 0.0020
510 BONE DENSITY DECREASED 61 0.0019
511 INTERVERTEBRAL DISC DEGENERATION 18 0.0019
512 MEDICATION ERROR 108 0.0019
513 FEELING JITTERY 37 0.0019
514 LOSS OF CONSCIOUSNESS 248 0.0019
515 DEMENTIA 54 0.0019
516 HYPERTENSION 409 0.0019
517 HEPATIC FUNCTION ABNORMAL 72 0.0019
518 CRYING 70 0.0019
519 VENTRICULAR EXTRASYSTOLES 20 0.0019
520 CHOLECYSTECTOMY 22 0.0019
521 ABNORMAL DREAMS 53 0.0019
522 END STAGE RENAL DISEASE 35 0.0019
523 MEMORY IMPAIRMENT 263 0.0019
524 METABOLIC ACIDOSIS 61 0.0019
525 MOVEMENT DISORDER 61 0.0019
526 GASTROINTESTINAL INFECTION 17 0.0019
527 ANAL INCONTINENCE 17 0.0019
528 ACUTE KIDNEY INJURY 286 0.0019
529 TUBULOINTERSTITIAL NEPHRITIS 35 0.0019
530 SENSORY LOSS 15 0.0019
531 HYPOKALAEMIA 86 0.0019
532 PHARYNGITIS 23 0.0019
533 IMPAIRED DRIVING ABILITY 21 0.0018
534 DERMATITIS ALLERGIC 23 0.0018
535 BRAIN OEDEMA 23 0.0018
536 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
537 APPENDICITIS 17 0.0018
538 SWOLLEN TONGUE 56 0.0018
539 CARDIAC ARREST 148 0.0018
540 HYPERHIDROSIS 230 0.0018
541 LYMPHADENOPATHY 63 0.0018
542 BLINDNESS TRANSIENT 13 0.0018
543 NERVOUS SYSTEM DISORDER 55 0.0018
544 TRICUSPID VALVE INCOMPETENCE 14 0.0018
545 GAIT DISTURBANCE 337 0.0018
546 ANHEDONIA 46 0.0017
547 NERVOUSNESS 91 0.0017
548 RESPIRATORY FAILURE 127 0.0017
549 OESOPHAGITIS 19 0.0017
550 PYELONEPHRITIS 15 0.0017
551 BODY TEMPERATURE DECREASED 17 0.0017
552 TOOTH FRACTURE 19 0.0017
553 VENTRICULAR FIBRILLATION 19 0.0017
554 GASTRITIS 45 0.0017
555 ABORTION INDUCED 16 0.0017
556 LIPASE INCREASED 13 0.0017
557 PHOTOSENSITIVITY REACTION 28 0.0017
558 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
559 PLATELET COUNT INCREASED 22 0.0017
560 PROTEINURIA 32 0.0017
561 HYPOTENSION 337 0.0017
562 MUSCULOSKELETAL STIFFNESS 146 0.0017
563 MICTURITION URGENCY 19 0.0017
564 CYTOPENIA 20 0.0016
565 IRRITABLE BOWEL SYNDROME 35 0.0016
566 CATARACT 97 0.0016
567 IRON DEFICIENCY ANAEMIA 15 0.0016
568 ARTHROPOD BITE 12 0.0016
569 ACCIDENTAL OVERDOSE 59 0.0016
570 PARALYSIS 23 0.0016
571 URINE OUTPUT DECREASED 14 0.0016
572 CHOLECYSTITIS 19 0.0016
573 PULMONARY HYPERTENSION 33 0.0016
574 LYMPHOCYTE COUNT DECREASED 28 0.0016
575 ROAD TRAFFIC ACCIDENT 66 0.0016
576 BACK INJURY 17 0.0016
577 MULTI-ORGAN FAILURE 27 0.0016
578 LOSS OF LIBIDO 14 0.0016
579 MIDDLE INSOMNIA 29 0.0016
580 HYPOALBUMINAEMIA 12 0.0015
581 FACE OEDEMA 26 0.0015
582 TRANSIENT ISCHAEMIC ATTACK 52 0.0015
583 HYPERKALAEMIA 54 0.0015
584 AMENORRHOEA 27 0.0015
585 DRY MOUTH 124 0.0015
586 RENAL DISORDER 71 0.0015
587 CONSTIPATION 332 0.0015
588 VITAMIN D DECREASED 13 0.0015
589 THERAPEUTIC RESPONSE UNEXPECTED 67 0.0015
590 DERMATITIS CONTACT 17 0.0015
591 LACERATION 14 0.0015
592 CHOKING 29 0.0015
593 DRUG WITHDRAWAL SYNDROME 130 0.0015
594 OEDEMA PERIPHERAL 180 0.0015
595 TOOTH ABSCESS 15 0.0015
596 LUNG INFILTRATION 13 0.0015
597 PERICARDIAL EFFUSION 34 0.0015
598 HAEMATEMESIS 37 0.0015
599 ABNORMAL WEIGHT GAIN 18 0.0015
600 VOMITING 685 0.0015
601 ACUTE CORONARY SYNDROME 12 0.0014
602 WHITE BLOOD CELL COUNT DECREASED 157 0.0014
603 RED BLOOD CELL SEDIMENTATION RATE INCREASED 16 0.0014
604 BEDRIDDEN 19 0.0014
605 EPILEPSY 44 0.0014
606 TENDERNESS 15 0.0014
607 NERVE INJURY 16 0.0014
608 RASH MACULO-PAPULAR 32 0.0014
609 VISION BLURRED 197 0.0014
610 FEELING ABNORMAL 343 0.0014
611 SYNCOPE 143 0.0014
612 PYREXIA 490 0.0014
613 EJECTION FRACTION DECREASED 22 0.0014
614 SCAB 16 0.0014
615 NEUTROPENIA 190 0.0014
616 NIGHTMARE 48 0.0014
617 HAEMORRHOIDS 27 0.0014
618 ARTERIOSCLEROSIS 13 0.0014
619 FOETAL EXPOSURE DURING PREGNANCY 112 0.0014
620 HERPES ZOSTER 79 0.0014
621 MUSCULAR WEAKNESS 156 0.0014
622 SENSORY DISTURBANCE 22 0.0014
623 SPLENOMEGALY 16 0.0014
624 PULMONARY CONGESTION 18 0.0014
625 EMOTIONAL DISORDER 42 0.0014
626 MUSCLE TIGHTNESS 22 0.0014
627 ACUTE RESPIRATORY FAILURE 26 0.0014
628 FALL 448 0.0013
629 GALLBLADDER DISORDER 24 0.0013
630 POLYNEUROPATHY 16 0.0013
631 GASTROOESOPHAGEAL REFLUX DISEASE 107 0.0013
632 DEEP VEIN THROMBOSIS 86 0.0013
633 LIVER DISORDER 58 0.0013
634 HYPOXIA 46 0.0013
635 SHOCK 30 0.0013
636 WRONG TECHNIQUE IN DRUG USAGE PROCESS 47 0.0013
637 SKIN LACERATION 14 0.0013
638 BACTERIAL INFECTION 24 0.0013
639 PULMONARY EMBOLISM 122 0.0013
640 BLOOD PRESSURE SYSTOLIC INCREASED 25 0.0013
641 MOUTH ULCERATION 27 0.0013
642 CONTUSION 123 0.0013
643 NEUROPATHY PERIPHERAL 121 0.0013
644 HYPOAESTHESIA ORAL 19 0.0013
645 TEMPERATURE INTOLERANCE 13 0.0013
646 GLOSSODYNIA 28 0.0012
647 PETECHIAE 13 0.0012
648 MYELODYSPLASTIC SYNDROME 18 0.0012
649 WEIGHT FLUCTUATION 13 0.0012
650 CONDITION AGGRAVATED 377 0.0012
651 DYSGEUSIA 92 0.0012
652 CENTRAL NERVOUS SYSTEM LESION 17 0.0012
653 HAEMOGLOBIN DECREASED 127 0.0012
654 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
655 BLOOD BILIRUBIN INCREASED 33 0.0012
656 BREAST PAIN 13 0.0012
657 TRANSAMINASES INCREASED 27 0.0012
658 DISABILITY 24 0.0012
659 GENERALISED OEDEMA 15 0.0012
660 BLADDER DISORDER 12 0.0012
661 DYSSTASIA 35 0.0012
662 BLOOD POTASSIUM DECREASED 36 0.0012
663 DYSURIA 44 0.0012
664 HEART RATE IRREGULAR 27 0.0012
665 DIZZINESS 595 0.0012
666 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
667 PRODUCT TASTE ABNORMAL 16 0.0012
668 BONE MARROW FAILURE 24 0.0012
669 OEDEMA 64 0.0012
670 ASTHENIA 443 0.0012
671 BLOOD PRESSURE DECREASED 78 0.0012
672 IMPAIRED GASTRIC EMPTYING 16 0.0012
673 RETCHING 25 0.0012
674 TOOTH DISORDER 26 0.0012
675 ROTATOR CUFF SYNDROME 15 0.0012
676 TENDONITIS 18 0.0012
677 HEPATIC ENZYME INCREASED 79 0.0012
678 HIATUS HERNIA 15 0.0012
679 GASTRIC ULCER 22 0.0012
680 REBOUND EFFECT 13 0.0011
681 PRODUCT USE IN UNAPPROVED INDICATION 284 0.0011
682 JOINT STIFFNESS 30 0.0011
683 ARRHYTHMIA 54 0.0011
684 INJURY 80 0.0011
685 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
686 DISEASE RECURRENCE 54 0.0011
687 SEIZURE 131 0.0011
688 OSTEOARTHRITIS 48 0.0011
689 EAR PAIN 22 0.0011
690 SKIN LESION 31 0.0011
691 WEIGHT DECREASED 315 0.0011
692 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
693 NIGHT SWEATS 36 0.0011
694 VERTIGO 68 0.0011
695 TOOTH LOSS 23 0.0011
696 NECK PAIN 62 0.0011
697 URINARY TRACT INFECTION 189 0.0011
698 BACK DISORDER 18 0.0011
699 ANKLE FRACTURE 17 0.0011
700 BLOOD GLUCOSE FLUCTUATION 12 0.0011
701 DRUG DOSE OMISSION 181 0.0011
702 HEART RATE INCREASED 108 0.0011
703 PRODUCT ADMINISTRATION ERROR 22 0.0011
704 TINNITUS 50 0.0011
705 INFLAMMATION 56 0.0011
706 FEEDING DISORDER 22 0.0011
707 NAUSEA 858 0.0011
708 HEART RATE DECREASED 38 0.0011
709 HEPATOTOXICITY 24 0.0011
710 DRUG EFFECT DECREASED 58 0.0011
711 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 56 0.0011
712 MALNUTRITION 12 0.0011
713 CARPAL TUNNEL SYNDROME 15 0.0011
714 BLOOD CALCIUM DECREASED 12 0.0011
715 SKIN REACTION 15 0.0011
716 ORAL CANDIDIASIS 14 0.0011
717 PREMATURE BABY 32 0.0011
718 SEASONAL ALLERGY 15 0.0011
719 MIGRAINE 101 0.0011
720 RASH ERYTHEMATOUS 50 0.0010
721 CHEST PAIN 193 0.0010
722 POST PROCEDURAL COMPLICATION 20 0.0010
723 PALPITATIONS 121 0.0010
724 ORAL PAIN 23 0.0010
725 ACUTE HEPATIC FAILURE 14 0.0010
726 CORONARY ARTERY DISEASE 31 0.0010
727 PERIPHERAL COLDNESS 14 0.0010
728 MENORRHAGIA 20 0.0010
729 CHILLS 119 0.0010
730 THERAPEUTIC RESPONSE DECREASED 61 0.0010
731 SKIN ULCER 26 0.0010
732 THROAT TIGHTNESS 27 0.0010
733 GASTROENTERITIS VIRAL 18 0.0010
734 TOOTHACHE 18 0.0010
735 SCAR 17 0.0010
736 VIRAL INFECTION 33 0.0010
737 PRODUCT PHYSICAL ISSUE 20 0.0010
738 UNEVALUABLE EVENT 75 0.0010
739 DRUG PRESCRIBING ERROR 19 0.0010
740 ADVERSE REACTION 13 0.0010
741 THERAPY NON-RESPONDER 44 0.0010
742 DECREASED APPETITE 227 0.0010
743 OSTEOPOROSIS 40 0.0010
744 SURGERY 57 0.0010
745 QUALITY OF LIFE DECREASED 13 0.0010
746 BRAIN FOG 15 0.0010
747 DEAFNESS 25 0.0010
748 RECTAL HAEMORRHAGE 41 0.0010
749 UPPER RESPIRATORY TRACT INFECTION 44 0.0010
750 PNEUMONIA 305 0.0009
751 MALAISE 412 0.0009
752 HEPATITIS 24 0.0009
753 GYNAECOMASTIA 29 0.0009
754 BLOOD GLUCOSE DECREASED 45 0.0009
755 PLEURAL EFFUSION 57 0.0009
756 HAEMATURIA 32 0.0009
757 DRUG RESISTANCE 24 0.0009
758 INFUSION SITE PAIN 12 0.0009
759 INTESTINAL OBSTRUCTION 35 0.0009
760 LOWER RESPIRATORY TRACT INFECTION 42 0.0009
761 DYSPHONIA 54 0.0009
762 OSTEOPENIA 14 0.0009
763 SWELLING FACE 60 0.0009
764 LYMPHOPENIA 13 0.0009
765 PALLOR 25 0.0009
766 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
767 LOCAL SWELLING 16 0.0009
768 FATIGUE 707 0.0009
769 CARDIOGENIC SHOCK 13 0.0009
770 PARAESTHESIA 142 0.0009
771 PARAESTHESIA ORAL 13 0.0009
772 THERAPY PARTIAL RESPONDER 14 0.0009
773 FOOT FRACTURE 17 0.0009
774 SKIN DISCOLOURATION 41 0.0009
775 CHEST DISCOMFORT 91 0.0009
776 EYE PAIN 50 0.0009
777 HEMIPARESIS 15 0.0009
778 DIARRHOEA 571 0.0009
779 RASH 385 0.0009
780 BLOOD PRESSURE INCREASED 135 0.0009
781 PNEUMOTHORAX 14 0.0009
782 GLAUCOMA 17 0.0009
783 DRUG INEFFECTIVE 1162 0.0009
784 STAPHYLOCOCCAL INFECTION 29 0.0009
785 SEPSIS 98 0.0009
786 VISUAL ACUITY REDUCED 29 0.0009
787 RESPIRATORY DISTRESS 24 0.0009
788 ADVERSE DRUG REACTION 78 0.0009
789 DRUG-INDUCED LIVER INJURY 27 0.0009
790 ILL-DEFINED DISORDER 52 0.0009
791 ABDOMINAL PAIN 199 0.0009
792 ABDOMINAL DISTENSION 89 0.0009
793 NEPHROLITHIASIS 39 0.0008
794 DRUG ADMINISTRATION ERROR 26 0.0008
795 BLOOD GLUCOSE INCREASED 159 0.0008
796 MYALGIA 143 0.0008
797 BRONCHITIS 62 0.0008
798 ANAEMIA 159 0.0008
799 RASH MACULAR 29 0.0008
800 HYPOAESTHESIA 123 0.0008
801 EYE DISORDER 27 0.0008
802 OROPHARYNGEAL PAIN 76 0.0008
803 EMOTIONAL DISTRESS 99 0.0008
804 ASCITES 24 0.0008
805 DYSPEPSIA 80 0.0008
806 RENAL INJURY 24 0.0008
807 HOSPITALISATION 124 0.0008
808 RASH PAPULAR 18 0.0008
809 OXYGEN SATURATION DECREASED 45 0.0008
810 THROMBOCYTOPENIA 89 0.0008
811 COLD SWEAT 14 0.0008
812 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
813 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
814 HEAD DISCOMFORT 14 0.0008
815 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 56 0.0008
816 MATERNAL EXPOSURE DURING PREGNANCY 70 0.0008
817 HEADACHE 492 0.0008
818 CHOLESTASIS 15 0.0008
819 HOT FLUSH 58 0.0008
820 RESPIRATORY TRACT INFECTION 20 0.0008
821 KIDNEY INFECTION 15 0.0008
822 MUSCULOSKELETAL PAIN 40 0.0008
823 HEPATIC FAILURE 23 0.0008
824 GENERAL PHYSICAL HEALTH DETERIORATION 88 0.0008
825 MUSCLE SPASMS 139 0.0008
826 LIP SWELLING 25 0.0007
827 PRODUCT SUBSTITUTION ISSUE 43 0.0007
828 LIVER FUNCTION TEST INCREASED 16 0.0007
829 PAIN IN JAW 21 0.0007
830 FIBROMYALGIA 18 0.0007
831 NEURALGIA 18 0.0007
832 FAECES DISCOLOURED 16 0.0007
833 BLOOD URINE PRESENT 14 0.0007
834 LIMB INJURY 20 0.0007
835 DRUG INTOLERANCE 71 0.0007
836 LIVER INJURY 18 0.0007
837 PLATELET COUNT DECREASED 78 0.0007
838 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 40 0.0007
839 CYSTITIS 23 0.0007
840 PELVIC PAIN 13 0.0007
841 ABDOMINAL PAIN LOWER 18 0.0007
842 EXPOSURE DURING PREGNANCY 44 0.0007
843 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
844 BLOOD PRESSURE ABNORMAL 14 0.0007
845 FEELING HOT 43 0.0007
846 CONJUNCTIVITIS 13 0.0007
847 MUSCULOSKELETAL DISCOMFORT 12 0.0007
848 ABDOMINAL PAIN UPPER 143 0.0007
849 OFF LABEL USE 608 0.0007
850 PRURITUS GENERALISED 15 0.0007
851 BACK PAIN 161 0.0007
852 MULTIPLE SCLEROSIS 33 0.0007
853 FUNGAL INFECTION 23 0.0007
854 DYSPNOEA 390 0.0007
855 DISCOMFORT 42 0.0007
856 RASH PRURITIC 37 0.0007
857 FEELING COLD 19 0.0007
858 MOBILITY DECREASED 49 0.0007
859 GASTROINTESTINAL DISORDER 61 0.0007
860 NASAL CONGESTION 40 0.0007
861 BURNING SENSATION 47 0.0007
862 SNEEZING 15 0.0007
863 DERMATITIS 14 0.0007
864 DYSPNOEA EXERTIONAL 25 0.0007
865 BLINDNESS 27 0.0007
866 VISUAL IMPAIRMENT 82 0.0007
867 PRESYNCOPE 16 0.0007
868 JOINT INJURY 14 0.0007
869 INTENTIONAL PRODUCT MISUSE 57 0.0007
870 DIVERTICULITIS 18 0.0006
871 FLUID RETENTION 33 0.0006
872 PULMONARY OEDEMA 29 0.0006
873 INFLUENZA LIKE ILLNESS 53 0.0006
874 DRY EYE 32 0.0006
875 HEPATIC CIRRHOSIS 12 0.0006
876 INFECTION 92 0.0006
877 SINUSITIS 65 0.0006
878 PAIN IN EXTREMITY 185 0.0006
879 BLOOD PRESSURE FLUCTUATION 15 0.0006
880 ABDOMINAL DISCOMFORT 104 0.0006
881 INFLUENZA 69 0.0006
882 ADVERSE EVENT 57 0.0006
883 HAEMATOCHEZIA 34 0.0006
884 HYPERSENSITIVITY 114 0.0006
885 LIMB DISCOMFORT 19 0.0006
886 CEREBRAL INFARCTION 15 0.0006
887 FLUSHING 62 0.0006
888 EAR INFECTION 16 0.0006
889 PAIN 368 0.0006
890 PRURITUS 229 0.0006
891 INTENTIONAL PRODUCT USE ISSUE 52 0.0006
892 ECZEMA 31 0.0006
893 OCULAR HYPERAEMIA 28 0.0006
894 ERYTHEMA 121 0.0006
895 CARDIAC FAILURE CONGESTIVE 47 0.0006
896 COLITIS 22 0.0006
897 MYOCARDIAL INFARCTION 101 0.0006
898 DRUG EFFECT INCOMPLETE 21 0.0006
899 LABORATORY TEST ABNORMAL 17 0.0006
900 CHROMATURIA 13 0.0006
901 PRODUCT AVAILABILITY ISSUE 13 0.0006
902 MULTIPLE SCLEROSIS RELAPSE 39 0.0006
903 GAIT INABILITY 19 0.0006
904 FLATULENCE 32 0.0006
905 CEREBROVASCULAR ACCIDENT 95 0.0006
906 MENSTRUATION IRREGULAR 15 0.0006
907 JAUNDICE 15 0.0006
908 CARDIAC DISORDER 52 0.0006
909 GASTRIC DISORDER 19 0.0006
910 SEPTIC SHOCK 24 0.0006
911 ABORTION SPONTANEOUS 22 0.0005
912 IMPAIRED HEALING 18 0.0005
913 EPISTAXIS 41 0.0005
914 PRODUCT QUALITY ISSUE 74 0.0005
915 ARTHRALGIA 226 0.0005
916 ACUTE MYOCARDIAL INFARCTION 16 0.0005
917 ALOPECIA 105 0.0005
918 ARTHRITIS 42 0.0005
919 THERAPY CESSATION 27 0.0005
920 PRODUCTIVE COUGH 25 0.0005
921 ANGINA PECTORIS 15 0.0005
922 ASTHMA 59 0.0005
923 CARDIOVASCULAR DISORDER 13 0.0005
924 DERMATITIS ATOPIC 27 0.0005
925 LUNG DISORDER 25 0.0005
926 WHEEZING 30 0.0005
927 ILLNESS 52 0.0005
928 NASOPHARYNGITIS 93 0.0005
929 ARTHROPATHY 28 0.0005
930 WOUND 14 0.0005
931 LOCALISED INFECTION 12 0.0005
932 ATRIAL FIBRILLATION 48 0.0005
933 PRODUCT DOSE OMISSION 32 0.0005
934 FREQUENT BOWEL MOVEMENTS 13 0.0005
935 NEEDLE ISSUE 14 0.0005
936 COUGH 134 0.0005
937 ACNE 36 0.0005
938 INCORRECT DOSE ADMINISTERED 107 0.0005
939 RESPIRATORY DISORDER 14 0.0005
940 PANCYTOPENIA 26 0.0005
941 SWELLING 43 0.0005
942 INTENTIONAL DOSE OMISSION 13 0.0005
943 PSORIASIS 59 0.0005
944 RHINORRHOEA 29 0.0004
945 STOMATITIS 27 0.0004
946 PERIPHERAL SWELLING 68 0.0004
947 DRUG DEPENDENCE 70 0.0004
948 JOINT SWELLING 52 0.0004
949 EYE SWELLING 16 0.0004
950 BONE PAIN 25 0.0004
951 PRODUCT DOSE OMISSION ISSUE 124 0.0004
952 COVID-19 73 0.0004
953 SKIN EXFOLIATION 35 0.0004
954 HAEMORRHAGE 41 0.0004
955 THERAPY INTERRUPTED 28 0.0004
956 BLISTER 22 0.0004
957 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 70 0.0004
958 UNDERDOSE 28 0.0004
959 CARDIAC FAILURE 30 0.0004
960 LACTIC ACIDOSIS 12 0.0004
961 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
962 THROAT IRRITATION 16 0.0004
963 PRODUCT USE ISSUE 67 0.0004
964 DRY SKIN 47 0.0004
965 INJECTION SITE MASS 13 0.0004
966 HYPOACUSIS 15 0.0003
967 ANGIOEDEMA 15 0.0003
968 CEREBRAL HAEMORRHAGE 12 0.0003
969 URTICARIA 55 0.0003
970 THROMBOSIS 26 0.0003
971 VAGINAL HAEMORRHAGE 14 0.0003
972 LUNG NEOPLASM MALIGNANT 13 0.0003
973 TREATMENT FAILURE 26 0.0003
974 ANAPHYLACTIC REACTION 17 0.0003
975 DEPENDENCE 16 0.0003
976 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
977 PRODUCT STORAGE ERROR 25 0.0003
978 DEATH 233 0.0003
979 NEOPLASM MALIGNANT 18 0.0003
980 FEBRILE NEUTROPENIA 17 0.0003
981 DEVICE MALFUNCTION 18 0.0003
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 51 0.0003
983 INJECTION SITE BRUISING 20 0.0003
984 EYE IRRITATION 13 0.0002
985 NO ADVERSE EVENT 40 0.0002
986 RHEUMATOID ARTHRITIS 25 0.0002
987 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
988 DISEASE PROGRESSION 25 0.0002
989 INJECTION SITE PAIN 61 0.0002
990 SKIN BURNING SENSATION 14 0.0002
991 INJECTION SITE REACTION 13 0.0002
992 INJECTION SITE ERYTHEMA 20 0.0002
993 BREAST CANCER 15 0.0002
994 INJECTION SITE HAEMORRHAGE 12 0.0002